Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2960681000168117 | Camptosar (irinotecan hydrochloride trihydrate 100 mg / 5 mL) injection, 1 x 5 mL vial (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2960691000168119 | Camptosar 100 mg/5 mL injection, 5 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Camptosar 100 mg/5 mL injection, 5 mL vial | has TPUU | Camptosar 100 mg/5 mL injection, 5 mL vial | true | Inferred relationship | Some | 1 | |
| Camptosar 100 mg/5 mL injection, 5 mL vial | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Camptosar 100 mg/5 mL injection, 5 mL vial | Is a | Camptosar 100 mg/5 mL injection, 5 mL vial | true | Inferred relationship | Some | ||
| Camptosar 100 mg/5 mL injection, 5 mL vial | has container type | vial | true | Inferred relationship | Some | ||
| Camptosar 100 mg/5 mL injection, 5 mL vial | has TP | Camptosar | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR